Related Experiment Videos
The prognostic inhomogeneity in pT3 rectal carcinomas
S Merkel1, U Mansmann, M Siassi
1Department of Surgery, University of Erlangen, Germany. susanne.merkel@chir.imed.uni-erlangen.de
International Journal of Colorectal Disease
|November 1, 2001
Summary
Subdividing pT3 rectal tumors into pT3a (≤5mm invasion) and pT3b (>5mm invasion) significantly improves outcome prediction. This refined classification helps identify early-stage rectal cancer patients who may not require adjuvant treatment.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Research
Background:
- Prognostic stratification of rectal carcinomas is crucial for treatment planning.
- The current pT staging system for rectal cancer may require refinement for improved accuracy.
Purpose of the Study:
- To evaluate the impact of subdividing pT3 rectal carcinomas based on invasion depth on locoregional recurrence and survival rates.
- To assess the predictive value of an extended pT classification for rectal cancer outcomes.
Main Methods:
- Analysis of data from 853 patients in the Erlangen Registry for Colo-Rectal Carcinomas (ERCRC) and 600 patients in the Study Group for Colo-Rectal Carcinoma (SGCRC).
- Patients were staged I-III and treated with radical surgery alone.
- pT3 tumors were subclassified as pT3a (invasion ≤5 mm) and pT3b (invasion >5 mm) beyond the muscularis propria.
Main Results:
- In the ERCRC cohort, pT3b tumors showed significantly higher locoregional recurrence rates (26.3%) compared to pT3a tumors (10.4%) (P<0.0001).
- Cancer-related 5-year survival rates were substantially lower for pT3b (54.1%) versus pT3a (85.4%) (P<0.0001).
- Similar trends, though statistically marginal, were observed in the SGCRC cohort.
Conclusions:
- Subdivision of pT3 rectal carcinomas into pT3a and pT3b provides improved prognostic information.
- An extended pT classification (pT1-pT4) enhances the prediction of outcomes in rectal cancer.
- Stage II patients with pT3a and node-negative disease may not benefit from adjuvant therapy, suggesting a need for personalized treatment strategies.